标题
PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
作者
关键词
-
出版物
ONCOGENE
Volume 31, Issue 29, Pages 3397-3408
出版商
Springer Nature
发表日期
2011-11-21
DOI
10.1038/onc.2011.515
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The frequent co-expression of the oncogenes PIK3CA and PAK1 in oral carcinomas
- (2011) Hsi-Feng Tu et al. ORAL ONCOLOGY
- Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts
- (2010) Daniel M Appledorn et al. BMC CANCER
- PIK3CA Mutations in In situ and Invasive Breast Carcinomas
- (2010) A. Miron et al. CANCER RESEARCH
- Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India
- (2010) Indranil Chattopadhyay et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Rac–Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells
- (2010) L E Arias-Romero et al. ONCOGENE
- CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
- (2010) So Young Kim et al. PLoS One
- Pak protein kinases and their role in cancer
- (2009) Bettina Dummler et al. CANCER AND METASTASIS REVIEWS
- Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
- (2009) O. K. Mirzoeva et al. CANCER RESEARCH
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
- (2009) K. P. Hoeflich et al. CLINICAL CANCER RESEARCH
- ErbB receptors and signaling pathways in cancer
- (2009) Nancy E Hynes et al. CURRENT OPINION IN CELL BIOLOGY
- Non-redundancy within the RAS oncogene family: Insights into mutational disparities in cancer
- (2009) Ken S. Lau et al. MOLECULES AND CELLS
- Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer
- (2009) M. L. Sos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amplification of 11q13 in ovarian carcinoma
- (2008) Lindsay A. Brown et al. GENES CHROMOSOMES & CANCER
- Characterization of Ser338Phosphorylation for Raf-1 Activation
- (2008) Mengwei Zang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
- (2008) Jinyan Du et al. NATURE BIOTECHNOLOGY
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now